background preloader

Breast & Ovarian Cancer Guidelines

Facebook Twitter

Interventions to Improve Bone Mineral Density, Muscle Mass and Fat Mass among Breast Cancer Survivors: Journal of the American College of Nutrition: Vol 0, No 0. Body weight management in overweight and obese breast cancer survivors - Shaikh, H - 2020. Ovarian Cancer: Lifestyle, Diet and Nutrition: Nutrition and Cancer: Vol 0, No 0. The Metabolic Syndrome Is a Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis - FullText - Obesity Facts 2020, Vol. 13, No. 4. European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis - Maturitas. 3.3.1.

European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis - Maturitas

Summary recommendation. Consideration of Ketogenic Metabolic Therapy as a Complementary or Alternative Approach for Managing Breast Cancer. Introduction Breast cancer persists as a significant cause of morbidity and mortality in woman.

Consideration of Ketogenic Metabolic Therapy as a Complementary or Alternative Approach for Managing Breast Cancer

According to the American Cancer Society, the number of new cases and deaths from breast cancer in US woman is estimated to be 268,600 and 41,760, respectively, for 2019 (1). Indeed, breast cancer alone will account for 30% of all female cancers. Although the incidence of breast cancer is lower in black women than in white women, the death rate is 41% higher in blacks than in whites possibly due in part to diet and lifestyle (2). The failure to effectively manage malignant breast cancer, and most malignant cancers for that matter, comes in large part from a misunderstanding on the origin of cancer. 1 The absence of gene and chromosomal mutations in some cancers (6–9). 2 The presence and clonal expansion of numerous so-called driver gene mutations in a broad range of normal human tissues including breast tissue (11–15).

The Mitochondrial Metabolic Theory of Cancer Figure 1. Glutaminolysis 3. 7. Association between obesity and breast cancer: Molecular bases and the effect of flavonoids in signaling pathways: Critical Reviews in Food Science and Nutrition: Vol 0, No 0. Obesity is an abnormal or excessive accumulation of fat that leads to different health problems, such as cancer, where the adipocytes promote the proliferation, migration, and invasion of cancer cells, especially in the breast, where the epithelial cells are immersed in a fatty environment, and the interactions between these two types of cells involve, not only adipokines but also local pro-inflammatory mechanisms and hypoxic processes generating anti-apoptotic signals, which are a common result in leptin signaling.

Association between obesity and breast cancer: Molecular bases and the effect of flavonoids in signaling pathways: Critical Reviews in Food Science and Nutrition: Vol 0, No 0

The expression of the Vascular Endothelial Growth Factor (VEGF) and cyclin D1, results in the decrease in phosphorylation of AMPK, increasing the activity of the aromatase enzyme; alternatively, the adiponectin activates AMPK to reduce inflammation. Breast cancer statistics, 2019 - DeSantis - - CA: A Cancer Journal for Clinicians. Introduction Breast cancer is the most common cancer diagnosed among US women (excluding skin cancers) and is the second leading cause of cancer death among women after lung cancer.

Breast cancer statistics, 2019 - DeSantis - - CA: A Cancer Journal for Clinicians

Herein, the American Cancer Society provides its biennial update of the latest breast cancer statistics in the United States, including the estimated numbers of new cases and deaths by age in 2019; incidence rates and trends by age, stage at diagnosis, race/ethnicity, and breast cancer molecular subtype through 2016; mortality rates and trends by race/ethnicity and state through 2017; treatment patterns in 2016; and survival by race/ethnicity, stage at diagnosis, and breast cancer subtype. Self‐reported mammography prevalence in 2016 is also presented by state. Additional data are available from the companion report, Breast Cancer Facts & Figures (available at cancer.org/statistics). Materials and Methods Data Sources Statistical Analyses Selected Findings.

Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline: Journal of Clinical Oncology: Vol 0, No 0. Managing menopausal symptoms and associated clinical issues in breast cancer survivors. Dietary Guidelines for Breast Cancer Patients: A Critical Review. + Author Affiliations Address correspondence to HA-G (e-mail: hastiazaran@ciad.mx).

Dietary Guidelines for Breast Cancer Patients: A Critical Review

Abstract Current dietary guidelines for breast cancer patients (BCPs) fail to address adequate dietary intakes of macro- and micronutrients that may improve patients’ nutritional status. This review includes information from the PubMed and Biomed Central databases over the last 15 y concerning dietary guidelines for BCPs and the potential impact of a personalized, nutrient-specific diet on patients’ nutritional status during and after antineoplastic treatment.

Results indicated that BCPs should receive a nutritional assessment immediately after diagnosis. Keywords: Footnotes Supported by a fellowship from the National Research and Technology Council, Mexico (for ATL-M) . © 2017 American Society for Nutrition. Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement. American Institute for Cancer Research (AICR) Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment - Greenlee - 2017 - CA: A Cancer Journal for Clinicians. Systematic Review Methodology To update the previously published clinical practice guidelines, which were based on a systematic review of the literature from January 1, 1990 through December 31, 2013,[9] we conducted a systematic review of published RCTs from January 1, 2014 through December 31, 2015, using the same search criteria and process.

Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment - Greenlee - 2017 - CA: A Cancer Journal for Clinicians

The process followed the methods set forth by the Institute of Medicine on clinical guideline development.[11] The following databases were searched: Embase, MEDLINE, PsychINFO, and CINAHL. According to the clinical guideline development process outlined by the Institute of Medicine,[11] drafts prepared by the SIO Guideline Working Group were distributed to an interdisciplinary group of SIO internal and external reviewers. Reviewer comments, suggestions, and critiques were incorporated into the final version of these guidelines. Definitions of Complementary and Integrative Therapies Acetyl-L-carnitine Acupuncture Acupressure Aloe vera Ginger Ginseng Soy.

Breast Cancer Survivorship Care Guideline 2015. Abstract Answer questions and earn CME/CNE The purpose of the American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline is to provide recommendations to assist primary care and other clinicians in the care of female adult survivors of breast cancer.

Breast Cancer Survivorship Care Guideline 2015

A systematic review of the literature was conducted using PubMed through April 2015. eNews: Top 6 Nutrition (and Other) Myths on Breast Cancer Prevention. This article appears in the October 6, 2016 issue of AICR's eNews.

eNews: Top 6 Nutrition (and Other) Myths on Breast Cancer Prevention

Soy foods, sugar, red wine – there’s a lot of confusing information out there when it comes to what you can do to lower breast cancer risk. And while there are no guarantees when it comes to developing breast cancer, research shows that there are steps you can take to lower risk. Even better news: those same steps will help you reduce your risk of many other cancers, along with other chronic diseases.